The discovery of LY6E as a viable target for cancer intervention has sparked considerable investigation . Several protein programs are being tested with the purpose of selectively neutralizing LY6E's function and inducing an therapeutic outcome in those suffering with various malignancies . Hurdles remain in optimizing antibody delivery and mitigat